The mutation T477A in HIV-1 reverse transcriptase (RT) restores normal proteolytic processing of RT in virus with Gag-Pol mutated in the p51-RNH cleavage site

por Abram, Michael E, Sarafianos, Stefan G, Parniak, Michael A
Publicado 2010

Pango lineage designation and assignment using SARS-CoV-2 spike gene nucleotide sequences

por O’Toole, Áine, Pybus, Oliver G., Abram, Michael E., Kelly, Elizabeth J., Rambaut, Andrew
Publicado 2022

Lack of impact of pre-existing T97A HIV-1 integrase mutation on integrase strand transfer inhibitor resistance and treatment outcome

por Abram, Michael E., Ram, Renee R., Margot, Nicolas A., Barnes, Tiffany L., White, Kirsten L., Callebaut, Christian, Miller, Michael D.
Publicado 2017

Brief Report: Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Adults With Renal Impairment: 96-Week Results From...

por Post, Frank A., Tebas, Pablo, Clarke, Amanda, Cotte, Laurent, Short, William R., Abram, Michael E., Jiang, Shuping, Cheng, Andrew, Das, Moupali, Fordyce, Marshall W.
Publicado 2017

Durability of neutralizing RSV antibodies following nirsevimab administration and elicitation of the natural immune response to RSV infection in infants

por Wilkins, Deidre, Yuan, Yuan, Chang, Yue, Aksyuk, Anastasia A., Núñez, Beatriz Seoane, Wählby-Hamrén, Ulrika, Zhang, Tianhui, Abram, Michael E., Leach, Amanda, Villafana, Tonya, Esser, Mark T.
Publicado 2023

Global Molecular Epidemiology of Respiratory Syncytial Virus from the 2017−2018 INFORM-RSV Study

por Tabor, David E., Fernandes, Fiona, Langedijk, Annefleur C., Wilkins, Deidre, Lebbink, Robert Jan, Tovchigrechko, Andrey, Ruzin, Alexey, Kragten-Tabatabaie, Leyla, Jin, Hong, Esser, Mark T., Bont, Louis J., Abram, Michael E.
Publicado 2020

Brief Report: Long-Term (96-Week) Efficacy and Safety After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected, Virologically Suppressed Adults

por Raffi, François, Orkin, Chloe, Clarke, Amanda, Slama, Laurence, Gallant, Joel, Daar, Eric, Henry, Keith, Santana-Bagur, Jorge, Stein, David K., Bellos, Nicholaos, Scarsella, Anthony, Yan, Mingjin, Abram, Michael E., Cheng, Andrew, Rhee, Martin S.
Publicado 2017

94. Pooled analysis of nirsevimab resistance through 150 days post dose in preterm and term infants

por Abram, Michael E, Ahani, Bahar, Tabor, David E, Fernandes, Fiona, Wilkins, Deidre, Aksyuk, Anastasia A, Tuffy, Kevin M, Ji, Hong, Blaze, Christine, Brady, Tyler, Griffin, Pamela, Leach, Amanda, Villafana, Tonya L, Esser, Mark T
Publicado 2022

Qualification of a Biolayer Interferometry Assay to Support AZD7442 Resistance Monitoring

por Brady, Tyler, Zhang, Tianhui, Tuffy, Kevin M., Haskins, Nantaporn, Du, Qun, Lin, Jia, Kaplan, Gilad, Novick, Steven, Roe, Tiffany L., Ren, Kuishu, Rosenthal, Kim, McTamney, Patrick M., Abram, Michael E., Streicher, Katie, Kelly, Elizabeth J.
Publicado 2022

Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment: 48-Week Results From a Single-Arm...

por Pozniak, Anton, Arribas, Jose R., Gathe, Joseph, Gupta, Samir K., Post, Frank A., Bloch, Mark, Avihingsanon, Anchalee, Crofoot, Gordon, Benson, Paul, Lichtenstein, Kenneth, Ramgopal, Moti, Chetchotisakd, Ploenchan, Custodio, Joseph M., Abram, Michael E., Wei, Xuelian, Cheng, Andrew, McCallister, Scott, SenGupta, Devi, Fordyce, Marshall W.
Publicado 2016

Molecular and phenotypic characteristics of RSV infections in infants during two nirsevimab randomized clinical trials

por Ahani, Bahar, Tuffy, Kevin M., Aksyuk, Anastasia A., Wilkins, Deidre, Abram, Michael E., Dagan, Ron, Domachowske, Joseph B., Guest, Johnathan D., Ji, Hong, Kushnir, Anna, Leach, Amanda, Madhi, Shabir A., Mankad, Vaishali S., Simões, Eric A. F., Sparklin, Benjamin, Speer, Scott D., Stanley, Ann Marie, Tabor, David E., Hamrén, Ulrika Wählby, Kelly, Elizabeth J., Villafana, Tonya
Publicado 2023

Global molecular diversity of RSV – the “INFORM RSV” study

por Langedijk, Annefleur C., Lebbink, Robert Jan, Naaktgeboren, Christiana, Evers, Anouk, Viveen, Marco C., Greenough, Anne, Heikkinen, Terho, Stein, Renato T., Richmond, Peter, Martinón-Torres, Federico, Nunes, Marta, Hosoya, Mitsuaki, Keller, Christian, Bauck, Monika, Cohen, Robert, Papenburg, Jesse, Pernica, Jeffrey, Hennus, Marije P., Jin, Hong, Tabor, David E., Tovchigrechko, Andrev, Ruzin, Alexey, Abram, Michael E., Wilkins, Deidre, Wildenbeest, Joanne G., Kragten-Tabatabaie, Leyla, Coenjaerts, Frank E. J., Esser, Mark T., Bont, Louis J.
Publicado 2020

The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in non-human primates and has an extended half-life in humans

por Loo, Yueh-Ming, McTamney, Patrick M., Arends, Rosalinda H., Abram, Michael E., Aksyuk, Anastasia A., Diallo, Seme, Flores, Daniel J., Kelly, Elizabeth J., Ren, Kuishu, Roque, Richard, Rosenthal, Kim, Streicher, Katie, Tuffy, Kevin M., Bond, Nicholas J., Cornwell, Owen, Bouquet, Jerome, Cheng, Lily I., Dunyak, James, Huang, Yue, Rosenbaum, Anton I., Reddy, Venkatesh Pilla, Andersen, Hanne, Carnahan, Robert H., Crowe, James E., Kuehne, Ana I., Herbert, Andrew S., Dye, John M., Bright, Helen, Kallewaard, Nicole L., Pangalos, Menelas N., Esser, Mark T.
Publicado 2022